UTH Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - United Therapeutics Corp

Watchlist Manager

Watchlist

Price: 430.9 EUR -0.35%

Market Cap: €12.2B

U	United Therapeutics Corp XMUN:UTH	US
	Industrias Penoles SAB de CV OTC:IPOAF	MX
	Pirelli and C. S.p.a MIL:PIRC	IT
	Virbac SA F:V16	FR

Profitability Summary

United Therapeutics Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

86%

Strong 3Y Average Gross Margin

88%

Declining Gross Margin

90% > 86%

Exceptional Operating Margin

44%

Strong 3Y Average Operating Margin

49%

Declining Operating Margin

52% > 44%

Exceptional Net Margin

42%

Strong 3Y Average Net Margin

41%

Net Margin is Increasing

41% > 42%

Exceptional Free Cash Flow Margin

34%

Strong 3Y Average Free Cash Flow Margin

34%

Free Cash Flow Margin is Increasing

32% > 34%

Positive ROE

19%

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

28%

ROIC is Increasing

25% > 28%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.